Related Experiment Video
Updated: Jul 28, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Infantile intestinal leiomyosarcoma: surgical resection (without adjuvant therapy) for cure
B B Simpson1, E M Reynolds, S H Kim
1Department of Pediatric Surgery, Massachusetts General Hospital, Boston 02114, USA.
Journal of Pediatric Surgery
|November 1, 1996
Summary
Infantile intestinal leiomyosarcomas are rare, but infants with these tumors have a favorable prognosis. Complete surgical removal leads to excellent outcomes, even without further treatment.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
Background:
- Leiomyosarcomas are rare in infants, with differing primary sites compared to adults.
- Adult prognostic indicators for leiomyosarcomas may not apply to pediatric cases.
Observation:
- A 7-week-old infant presented with intussusception and a cecal mass.
- The mass was diagnosed as an intermediate-grade leiomyosarcoma.
- The infant achieved disease-free survival for 3 years post-resection without adjuvant therapy.
Findings:
- Complete surgical excision is the primary curative treatment for infantile intestinal leiomyosarcomas.
- Infantile leiomyosarcomas appear less aggressive than adult counterparts.
- Histological prognostic factors from adult leiomyosarcomas are not directly applicable to infants.
Implications:
- Early diagnosis and complete resection are crucial for favorable outcomes in infantile intestinal leiomyosarcomas.
- Adjuvant therapy may not be necessary for infants with completely resected leiomyosarcomas.
- Further research is needed to establish infant-specific prognostic factors for this rare malignancy.

